CLLS - Cellectis S.A.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
19,171
19,171
73,949
73,949
15,190
Cost of revenue
1,772
1,772
36,275
36,275
11,392
Gross profit
17,399
17,399
37,674
37,674
3,798
Operating expenses
Research development
97,501
97,501
86,950
86,950
92,042
Selling general and administrative
17,494
17,494
44,201
44,201
43,017
Total operating expenses
107,065
107,065
123,111
123,111
127,350
Operating income or loss
-89,666
-89,666
-85,437
-85,437
-123,552
Interest expense
3,787
3,787
5,338
12,046
2,606
Total other income/expenses net
6,060
6,060
9,730
-10,730
3,810
Income before tax
-98,600
-98,601
-97,483
-97,483
-115,212
Income tax expense
87
87
-
0
0
Income from continuing operations
-98,688
-98,688
-97,483
-97,483
-115,212
Net income
-106,139
-106,139
-81,074
-81,074
-102,091
Net income available to common shareholders
-106,139
-106,139
-81,074
-81,074
-102,091
Basic EPS
-
-2.33
-2.55
-1.91
-2.41
Diluted EPS
-
-2.33
-2.55
-1.91
-2.41
Basic average shares
-
45,547
44,820
42,503
42,442
Diluted average shares
-
45,547
44,820
42,503
42,442
EBITDA
-
-89,666
-85,437
-85,437
-123,552